JP Morgan Chase’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
OIA
CCA
KF
AWM
KAS
ASN
JP Morgan Chase's BTAL Position: Q4 2025 in Review
JP Morgan Chase sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2025, closing a stake of 789 shares — an estimated $12.6K sold.
JP Morgan Chase first reported a position in BTAL in Q4 2022 and held it in 12 quarters. The position peaked at $1.67M in Q2 2024. 81 funds tracked by Wall St. Rank hold BTAL as of Q4 2025.
- JP Morgan Chase reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2025 after selling out during the quarter.
- JP Morgan Chase sold 789 AGF US Market Neutral Anti-Beta Fund shares in Q4 2025, an estimated $12.6K.
- JP Morgan Chase first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2022 and held it in 12 quarters.
- JP Morgan Chase's AGF US Market Neutral Anti-Beta Fund position peaked at $1.67M in Q2 2024.
- 81 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2025.
Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.